Aster Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.22K Sell
12
-886
-99% -$291K ﹤0.01% 678
2025
Q4
$315K Buy
+898
New +$303K 0.14% 138
2025
Q3
Sell
-2,705
Closed -$1.05M 1070
2025
Q2
$1.05M Buy
2,705
+2,582
+2,099% +$1.04M 0.24% 99
2025
Q1
$48.8K Buy
+123
New +$49.4K 0.01% 826
2024
Q4
Sell
-1,586
Closed -$825K 1215
2024
Q3
$825K Buy
+1,586
New +$847K 0.18% 145

Other funds holding ELV

Aster Capital Management's ELV Position: Q1 2026 in Review

Aster Capital Management reduced its Elevance Health (ELV) stake by 99% in Q1 2026, selling an estimated $291K and leaving 12 shares worth $5.22K. The position accounts for ﹤0.01% of the portfolio, ranked #678.

Aster Capital Management first reported a position in ELV in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.05M in Q2 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Aster Capital Management held 12 shares of Elevance Health worth $5.22K as of Q1 2026.
  • Aster Capital Management sold 886 Elevance Health shares in Q1 2026, an estimated $291K.
  • Elevance Health made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #678 holding.
  • Aster Capital Management first reported a position in Elevance Health in Q3 2024 and has held it in 5 quarters since.
  • Aster Capital Management's Elevance Health position peaked at $1.05M in Q2 2025.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.